| Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma. | |
| | |
MedLine Citation:
|
PMID: 17365853 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To analyse and compare the phospholipid and fatty acid composition of total lipids and the occurrence of lipid peroxidation and protein oxidation directly in erythrocytes or platelets from chronic obstructive pulmonary disease (COPD) and asthma patients. PATIENTS: Fifteen consecutive outpatients with COPD (all smokers) and asthma (non-smokers) recruited during a moderate-to-severe (COPD) or moderate (asthma) exacerbation. Fifteen subjects with smoking habits similar to those of COPD patients were studied as a control group. METHODS: Phospholipid and total fatty acid compositions were analysed by two-dimensional thin layer chromatography or gas chromatography-mass spectrometry, respectively. The lipid fluorescence of lipid extracts was measured by spectrofluorimetry. Protein carbonyl contents and profiles were measured by immunoblot detection. RESULTS: No differences were found either in erythrocyte or platelet cholesterol or phospholipid levels. Only a decrease in the content of phosphatidylserine + phosphatidylinositol (P<0.003) was detected in platelets from the asthma patients. In erythrocytes, the fatty acid profile changed in both lung pathologies, especially as regards polyunsaturated fatty acids (decreases in arachidonic and 22:4 fatty acid contents). Other observed changes were: COPD, an increase in palmitic fatty acid; asthma, an increase in oleic and decreases in eicosapentaenoic and 22:6 + 24:1 fatty acids. In platelets, the fatty acid profiles revealed many differences between both lung pathologies: COPD, a decrease in 18:1 and increases in 20:5 and 22:5 + 24:0; asthma, a decrease in 20:4 and increase in 22:6 + 24:1. In COPD vs. asthma patients, fatty acid changes were mainly detected in platelets, especially in 18-carbon species, with decreases in stearic and 18:1 fatty acids in the COPD patients. Protein oxidation levels were increased in both lung pathologies in both erythrocytes and platelets. CONCLUSIONS: COPD and asthma are associated with common or specific changes in the lipid composition of erythrocytes and/or platelets. The data point to lipid peroxidation and protein oxidation phenomena in both types of blood cell, although platelets would be more susceptible to stress. |
| | |
Authors:
|
Javier De Castro; Angel Hernández-Hernández; Marina C Rodríguez; José L Sardina; Marcial Llanillo; Jesús Sánchez-Yagüe |
Related Documents
:
|
8491163 - Fatty acid compositions of inositol and choline phospholipids of breast tumours and nor... 974153 - Positional distribution of fatty acids in rabbit lung phospholipids and triacylglycerol... 16852953 - Efficient light harvesting by using green zn-porphyrin-sensitized nanocrystalline tio2 ... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Platelets Volume: 18 ISSN: 0953-7104 ISO Abbreviation: Platelets Publication Date: 2007 Feb |
Date Detail:
|
Created Date: 2007-03-16 Completed Date: 2007-06-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9208117 Medline TA: Platelets Country: England |
Other Details:
|
Languages: eng Pagination: 43-51 Citation Subset: IM |
Affiliation:
|
Radiology Service, Santísima Trinidad Foundation Hospital, Salamanca, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Asthma / blood*, physiopathology Blood Platelets / chemistry* Blood Proteins / chemistry* Cell Membrane / chemistry Cholesterol / blood Chromatography, Thin Layer Erythrocyte Membrane / chemistry Erythrocytes / chemistry* Fatty Acids / blood*, classification Female Forced Expiratory Volume Gas Chromatography-Mass Spectrometry Humans Lipid Peroxidation Male Membrane Proteins / blood* Middle Aged Oxidation-Reduction Oxidative Stress Phospholipids / blood* Protein Carbonylation Pulmonary Disease, Chronic Obstructive / blood*, physiopathology Vital Capacity |
| Chemical | |
Reg. No./Substance:
|
0/Blood Proteins; 0/Fatty Acids; 0/Membrane Proteins; 0/Phospholipids; 57-88-5/Cholesterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Platelets possess functional TGF-beta receptors and Smad2 protein.
Next Document: Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopen...